31Mar 2017

BACTERIAL SPECTRUM IN EXACERBATION COPD PATIENTS.

  • Microbiologist. MD. PhD.TSMU the First University Clinic (Tbilisi, Georgia).
  • Head of Department of Internal Medicine. Professor. MD. PhD.TSMU the First University Clinic (Tbilisi, Georgia).
  • Head of Clinical Laboratory. Professor. MD. PhD.TSMU the First University Clinic (Tbilisi, Georgia).
  • Laborant Physician TSMU the First University Clinic (Tbilisi, Georgia).
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

The precise role of bacterial infection in the course of exacerbation COPD has been a source of controversy for decades.Chronic bacterial colonization of the lower airways contributes to airway inflammation; The course of COPD is characterized by intermittent exacerbacions of the disease.Approximately 40-50% acute exarbations are caused by bacteria, by viruses in 25%, and both viruses and bacteria in another 25%. Airway inflammation is increased during the exacerbation resulting in increased hyperinflation, reduced expiratory air flow and decreased gas exchange. Expectorated sputum is the most commonly used sample for diagnosis of lower respiratory tract infections(LRTI),which can be obtained easily and non-invasively. The bacteria are very common in the lower respiratory tract of patients with COPD and cause inflammation. We have shown that among microorganisms causing acute exacerbations of COPD in our patients prevailed gram negative Enterobacteriaceae family and comparatively high resistance against cephalosporins and fluoroquinolones related to wide usage of antibiotics of this group for chemoprophilaxis.


  1. Isenberg HD, Baron EJ, Damato RF, et al. Recommendations for isolation of bacteria from clinical specimens. In: Balows A, Hausler WJ Jr, Herrmann KL, et al., editors.Manual of Clinical Microbiology.?Washington, DC: American Society for Microbiology; 2011;
  2. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Results from the lung health study.Am J Respir Crit Care Med.?2010;
  3. Karnak D, Beng Sun S, Beder S, et al. Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD)Respir Med.?2012;
  4. Lieberman D, Lieberman D, Ben-Yaakov M, et al. Infectious etiologies in acute exacerbation of COPD.Diagn Microbiol Infect Dis.?2011;
  5. Lieberman D, Lieberman D, Ben-Yaakov M, et al. Chlamydia pneumonia infection in acute exacerbations of chronic obstructive pulmonary disease: Analysis of 250 hospitalizations.Eur J Clin Microbial Infect Dis.?2011;
  6. Lieberman D, Lieberman D, Shmarkov, et al. Serologic evidence of Legionella species infection in acute exacerbation of COPD.Eur Respir J.?2002;
  7. Miravitlles M, Espinosa C, Fernandez-Laso E, et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD.?2013;
  8. Mogulkoc N, Karakurt S, Isalska B, et al. Acute purulant exacerbations of chronic obstructive pulmonary disease and Chlamydia pneumonia infection.Am J Respir Crit Care Med.?2014;
  9. Monso E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.Am J Respir Crit Care Med.?2010;
  10. Murray PR, Washington JA. Microscopic and bacteriologic analysis of expoctrated sputum.Mayo Clin Proc.?2012;

[Tamar Didbaridze, Kakhaber Chelidze, Nino Gogokhia and Khatia Mikaberidze. (2017); BACTERIAL SPECTRUM IN EXACERBATION COPD PATIENTS. Int. J. of Adv. Res. 5 (Mar). 2028-2030] (ISSN 2320-5407). www.journalijar.com


Tamar Didbaridze1, Kakhaber Chelidze2,Nino Gogokhia3, Khati


DOI:


Article DOI: 10.21474/IJAR01/3721      
DOI URL: http://dx.doi.org/10.21474/IJAR01/3721